APA

Seino Y., Min K. W., Niemoeller E. & Takami A. (20130418). Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). : Diabetes, obesity & metabolism.

Chicago

Seino Y, Min K W, Niemoeller E and Takami A. 20130418. Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). : Diabetes, obesity & metabolism.

Harvard

Seino Y., Min K. W., Niemoeller E. and Takami A. (20130418). Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). : Diabetes, obesity & metabolism.

MLA

Seino Y, Min K W, Niemoeller E and Takami A. Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). : Diabetes, obesity & metabolism. 20130418.